Omada Health (OMDA) Fundamental Analysis: Revenue, Earnings & Valuation

9.20 / 10

Outperform

Fundamental score is 9.2/10, driven by solid profit growth (72.9% YoY) and strong operating cash flow (153% YoY). Asset‑MV and cash‑MV contribute positively, while PB‑ROE and cash‑per‑share growth are weaker. Overall, fundamentals are rated Outperform.

Analysis Checks(5/10)

Revenue-MV

Value-0.52

Score0/3

Weight-39.58%

1M Return-6.46%

Net cash flow from operating activities per share (YoY growth rate %)

Value-29.92

Score0/3

Weight-19.89%

1M Return-3.08%

PB-ROE

Value1.82

Score0/3

Weight-8.25%

1M Return-1.30%

Basic earnings per share (YoY growth rate %)

Value94.27

Score2/3

Weight13.92%

1M Return1.70%

Total profit (YoY growth rate %)

Value72.89

Score2/3

Weight16.28%

1M Return1.87%

Net cash flow from operating activities (YoY growth rate %)

Value153.40

Score2/3

Weight13.42%

1M Return1.55%

Cash-UP

Value0.36

Score1/3

Weight5.49%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value94.27

Score2/3

Weight10.18%

1M Return1.25%

Asset-MV

Value-0.55

Score3/3

Weight97.06%

1M Return9.13%

Cash-MV

Value-0.34

Score1/3

Weight11.36%

1M Return1.42%

Is OMDA fundamentally strong?

OMDA scores 9.20/10 on fundamentals and holds a Discounted valuation at present. Backed by its -8.68% ROE, -4.91% net margin, -58.15 P/E ratio, 3.24 P/B ratio, and 94.27% earnings growth, these metrics solidify its Outperform investment rating.